BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12412382)

  • 1. Bone marrow or peripheral blood as a source of stem cells for allogeneic transplantation.
    Bacigalupo A; Frassoni F; Van Lint MT
    Haematologica; 2002 Aug; 87(8 Suppl):4-8. PubMed ID: 12412382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
    Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
    Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.
    Eapen M; Horowitz MM; Klein JP; Champlin RE; Loberiza FR; Ringdén O; Wagner JE
    J Clin Oncol; 2004 Dec; 22(24):4872-80. PubMed ID: 15520055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow.
    Arcese W; Aversa F; Bandini G; De Vincentiis A; Falda M; Lanata L; Lemoli RM; Locatelli F; Majolino I; Zanon P; Tura S
    Haematologica; 1998 Feb; 83(2):159-82. PubMed ID: 9549928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts.
    Behringer D; Bertz H; Schmoor C; Berger C; Dwenger A; Finke J
    Bone Marrow Transplant; 1999 Aug; 24(3):295-302. PubMed ID: 10455369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Pession A; Rondelli R; Paolucci P; Pastore G; Dini G; Bonetti F; Madon E; Mandelli F; Zanesco L; Uderzo C; Prete A; Rabusin M; Ugazio A; Di Bartolomeo P; Favre C; Bojd-Faulkner L; Poggi V; Luksch R; Donfrancesco A; Argiolu F; La Nasa G; Amici A; Locatelli F
    Haematologica; 2000 Jun; 85(6):638-46. PubMed ID: 10870122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
    Watanabe T; Kawano Y; Watanabe A; Takaue Y
    Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow or peripheral blood as a source of stem cells for allogeneic transplants.
    Bacigalupo A; Frassoni F; Van Lint MT
    Curr Opin Hematol; 2000 Nov; 7(6):343-7. PubMed ID: 11055506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
    Uzunel M; Remberger M; Sairafi D; Hassan Z; Mattsson J; Omazic B; Barkholt L; Ringdén O
    Transplantation; 2006 Oct; 82(7):913-9. PubMed ID: 17038906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
    Bertolini F; de Vincentiis A; Lanata L; Lemoli RM; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S
    Haematologica; 1997; 82(2):220-38. PubMed ID: 9175330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.